NCT00161759View on ClinicalTrials.gov

Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

January 31, 2004

Conditions
Burns
Interventions
DRUG

Sheet skin grafts affixed with Fibrin Sealant (lyophilized) with 4 IU/mL Thrombin

Trial Locations (12)

30909

Joseph M. Still Burn Center at Doctors Hospital, Augusta

36617

University of South Alabama Medical Center, Mobile

45229

Shriners Hospitals for Children, Cincinnati

60153

Loyola University Medical Center, Maywood

85008

Maricopa Medical Center, Phoenix

95817

University of California Davis Medical Center; Shriners Hospitals for Children, Sacramento

98104

University of Washington Burn Center, Seattle

92868-3298

UCI Medical Center, Orange

92103-8896

UCSD Medical Center, San Diego

06610

Bridgeport Hospital, Bridgeport

45409-2722

Wright State University, Miami Valley Hospital, Dayton

77550-2725

Shriners Hospitals for Children, Galveston, Galveston

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT00161759 - Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds | Biotech Hunter | Biotech Hunter